Los Angeles Business Journal

Melanoma Drug Shows Promise in Key Trial

Wednesday, March 20, 2013

Amgen Inc. said its experimental and novel treatment for advanced melanoma met the main goal of a late-stage clinical trial by demonstrating a durable response in significantly more patients than a comparison treatment, the New York Times and Reuters report.